At a glance
ClinicalIndex Comparison RecordPhase 2Completed· 202 enrolled
Drug / intervention
Diclofenac Test (lower dose) +3 moredrug
Likely dose
Celecoxib 400 mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Phase 2, Randomized, Double-Blind, Single-Dose, Parallel-Group, Active- and Placebo-Controlled Study of Diclofenac [Test] Capsules for the Treatment of Pain After Surgical Removal of Impacted Third Molars
In Brief
A Phase 2 clinical trial evaluating Diclofenac Test (lower dose), Diclofenac Test (upper dose), and 2 other interventions for Dental Pain. Completed, enrolled 202 participants across 1 site.
Detailed Summary
The purpose of this study is to determine whether Diclofenac Test Formulation Capsules are safe and effective for the treatment of dental pain.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsDental Pain
CountriesUnited States
Collaborators--
Timeline
Phase 2CompletedFinished
20102011201220132014201520162017201820192020202120222023202420252026
Enrollment StartSep 2009
First PostedSep 2009
Primary CompletionDec 2009
TodayJul 2026
First PostedSep 28, 2009
Enrollment StartSep 1, 2009
Primary CompletionDec 1, 2009
TodayJul 2, 2026
Enrollment to primary: 3 monthsPosted 16.8 years ago
Interventions
Diclofenac Test (lower dose)drug
18-mg Single dose
Diclofenac Test (upper dose)drug
35-mg Single dose
Celecoxib 400 mgdrug
Capsules 2 x 200 mg Single-dose
Placebodrug
Capsules 2 Single-dose